2021
|
Sign up to set email alerts
Current and Future Perspectives for the Cryopreservation of Cord Blood Stem Cells
Search citation statements
Order By: Relevance
Paper Sections
Select...
28
8
1
0
Citation Types
0
18
0
2
Year Published
Range
2021
20212026
2026Publication Types
Select...
28
6
1
1
Relationship
0
36
Authors
Journals
Cited by 36 publications
(20 citation statements)
References 100 publications
0
18
0
2
Order By: Relevance
Smart CitationsHow this paper cites the one you are viewing
“…Dimethyl sulfoxide (DMSO) remains the preferred cryoprotectant in cell cryopreservation [ 45 ]. However, its toxicity has long been a concern.…”
Section: Discussion
mentioning
confidence: 99%
Smart CitationsHow this paper cites the one you are viewing
“…Dimethyl sulfoxide (DMSO) remains the preferred cryoprotectant in cell cryopreservation [ 45 ]. However, its toxicity has long been a concern.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…1 IC 50 values were generated from nonlinear regression curves fitted to points on a normalized rate vs. log concentration graph. 2 A dose-response relationship was not observed for concentrations up to 100 mM.…”
Section: Toxicity Of Phosphonates 5 and 6 In Hepg2 Cells
mentioning
confidence: 96%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The autologous nature of these cells reduces the risk of immune rejection, making them a highly valuable resource for personalized medicine. Cord blood is another valuable source of HSCs [ 63 ], which are essential for the maintenance and repair of the hematopoietic system. Storing cord blood at birth ensures a readily available source of young and healthy HSCs that can be used for hematopoietic stem cell transplantation (HSCT) in the future.…”
Section: Adult Stem Cell Transplantation
mentioning
confidence: 99%
Smart CitationsHow this paper cites the one you are viewing
“…Dimethyl sulfoxide (DMSO) remains the preferred cryoprotectant in cell cryopreservation [ 45 ]. However, its toxicity has long been a concern.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…1 IC 50 values were generated from nonlinear regression curves fitted to points on a normalized rate vs. log concentration graph. 2 A dose-response relationship was not observed for concentrations up to 100 mM.…”
Section: Toxicity Of Phosphonates 5 and 6 In Hepg2 Cells
mentioning
confidence: 96%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The autologous nature of these cells reduces the risk of immune rejection, making them a highly valuable resource for personalized medicine. Cord blood is another valuable source of HSCs [ 63 ], which are essential for the maintenance and repair of the hematopoietic system. Storing cord blood at birth ensures a readily available source of young and healthy HSCs that can be used for hematopoietic stem cell transplantation (HSCT) in the future.…”
Section: Adult Stem Cell Transplantation
mentioning
confidence: 99%
Smart CitationsHow this paper cites the one you are viewing
“…Dimethyl sulfoxide (DMSO) remains the preferred cryoprotectant in cell cryopreservation [ 45 ]. However, its toxicity has long been a concern.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…1 IC 50 values were generated from nonlinear regression curves fitted to points on a normalized rate vs. log concentration graph. 2 A dose-response relationship was not observed for concentrations up to 100 mM.…”
Section: Toxicity Of Phosphonates 5 and 6 In Hepg2 Cells
mentioning
confidence: 96%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The autologous nature of these cells reduces the risk of immune rejection, making them a highly valuable resource for personalized medicine. Cord blood is another valuable source of HSCs [ 63 ], which are essential for the maintenance and repair of the hematopoietic system. Storing cord blood at birth ensures a readily available source of young and healthy HSCs that can be used for hematopoietic stem cell transplantation (HSCT) in the future.…”
Section: Adult Stem Cell Transplantation
mentioning
confidence: 99%
